X0306 4 2019-05-08 0 0001099800 Edwards Lifesciences Corp EW 0001196661 BOBO DONALD E JR C/O EDWARDS LIFESCIENCES ONE EDWARDS WAY IRVINE CA 92614 0 1 0 0 CVP, Strategy/Corp Development Common Stock 2019-05-08 4 A 0 1925 0 A 21040.3275 D Common Stock 12619.1051 I 401(k) Common Stock 176 I By Son Common Stock 46832 I By Trust Employee Stock Option (Right to Acquire) 177.77 2019-05-08 4 A 0 18900 0 A 2019-06-08 2026-05-07 Common Stock 18900 18900 D Performance Rights 2019-05-08 4 A 0 2400 0 A 2022-05-08 2026-05-07 Common Stock 2400 2400 D These restricted stock units were granted on May 8, 2019 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become 50% vested three years after the grant date and 50% vested four years after the grant date. Shares represented on the most recent statement of Issuer's 401(k) Plan Administrator. These options were granted on May 8, 2019 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal annual installments. Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 8, 2019 and scheduled to vest on May 8, 2022. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards. This Form 4 reflects changes in beneficial ownership only, it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Linda J. Park, Attorney-in-Fact 2019-05-10